Cited by 146Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment ResearchAmyloidosis: Diagnosis, Treatment, Outcomes

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study

Open access

Kioumourtzoglou, Marianthi-Anna, Rotem, Ran S., Seals, Ryan M., Gredal, Ole, Hansen, Johnni, Weisskopf, Marc G.·2015·JAMA Neurology

DOI 10.1001/jamaneurol.2015.0910PMC PMC4975611

Open this paper in CoChat — free account Open PDF

Abstract

IMPORTANCE: Although prior studies have suggested a role of cardiometabolic health on pathogenesis of amyotrophic lateral sclerosis (ALS), the association with diabetes mellitus has not been widely examined. Amyotrophic lateral sclerosis is the most common motor neuron disorder. Several vascular risk factors have been associated with decreased risk for ALS. Although diabetes is also a risk factor for vascular disease, the few studies of diabetes and ALS have been inconsistent. OBJECTIVE: To examine the association between diabetes and obesity, each identified through International Statistical Classification of Diseases, Eighth or Tenth Revision codes in a hospital registry, and ALS using data from the Danish National Registers. DESIGN, SETTING, AND PARTICIPANTS: Population-based nested case-control study of 3650 Danish residents diagnosed as having ALS between January 1, 1982, and December 31, 2009, and 365,000 controls (100 for each ALS case) matched on age and sex. The analysis was conducted in September and October 2014. MAIN OUTCOMES AND MEASURES: Adjusted odds ratio for ALS associated with diabetes or obesity diagnoses at least 3 years prior to the ALS diagnosis date. RESULTS: When considering diabetes and our obesity indicator together, the estimated odds ratio for ALS was 0.61 (95% CI, 0.46-0.80) for diabetes and 0.81 (95% CI, 0.57-1.16) for obesity. We observed no effect modification on the association with diabetes by sex. We did find a significant modification by age at ALS diagnosis and age at first mention of diabetes in the hospital registers. The protective association was stronger with increasing age at ALS diagnosis (P = .01), and the odds ratio for first mention of diabetes was 1.66 (95% CI, 0.85-3.21) before age 40 years but 0.52 (95% CI, 0.39-0.70) for older ages. These results are consistent with different associations for type 1 vs type 2 diabetes. CONCLUSIONS AND RELEVANCE: In this Danish nationwide study to investigate the association between diabetes and ALS diagnosis, our findings are in agreement with previous reports of a protective association between vascular risk factors and ALS and suggest that type 2 diabetes, but not type 1, is protective for ALS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2015.0910

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global Prevalence of Diabetes
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
The Danish Civil Registration System
Pedersen, C. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,713
Amyotrophic lateral sclerosis
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
The Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Rathmann, W., & Giani, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2568 · Cited by 2,008
Amyotrophic Lateral Sclerosis
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,913
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210
Type 1 diabetes
Daneman, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68341-4 · Cited by 954

Show all 60 references

Sorted by citations

Neurofilaments: neurobiological foundations for biomarker applications
Gafson, A., Barthélemy, N. R., Bomont, P., Carare, R. O., Durham, H. D., Julien, J., Kühle, J., Leppert, D., Nixon, R. A., Weller, R. O., et al. (2020) · Brain · doi:10.1093/brain/awaa098 · Cited by 339
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 316
Energy metabolism in ALS: an underappreciated opportunity?
Vandoorne, T., Bock, K. D., & Bosch, L. V. D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1835-x · Cited by 260
The multistep hypothesis of ALS revisited: The role of genetic mutations
Chiò, A., Mazzini, L., D'Alfonso, S., Corrado, L., Canosa, A., Moglia, C., Manera, U., Bersano, E., Brunetti, M., Barberis, M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005996 · Cited by 212
Dietary habits, lifestyle factors and neurodegenerative diseases
Popa‐Wagner, A., Dumbrava, D., Dumitrascu, D., Căpitănescu, B., Petcu, E. B., Surugiu, R., & Fang, W.-H. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266045 · Cited by 190
Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis
Lu, C., Allen, K., Oei, F., Leoni, E., Kühle, J., Tree, T. I. M., Fratta, P., Sharma, N., Sidle, K. C. L., Howard, R., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000244 · Cited by 181
Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
Peng, B., Yang, Q., B Joshi, R., Liu, Y., Akbar, M., Song, B.-J., Zhou, S., & Wang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072316 · Cited by 156
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20‐year follow‐up of the Swedish AMORIS cohort
Mariosa, D., Hammar, N., Malmström, H., Ingre, C., Jungner, I., Ye, W., Fang, F., & Walldius, G. (2017) · Annals of Neurology · doi:10.1002/ana.24936 · Cited by 151
Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice
Zu, T., Guo, S., Bardhi, O., Ryskamp, D. A., Li, J., Khoramian Tusi, S., Engelbrecht, A., Klippel, K., Chakrabarty, P., Nguyen, L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005748117 · Cited by 133
Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study
Rajkumar, A. P., Horsdal, H. T., Wimberley, T., Cohen, D., Mors, O., Børglum, A. D., & Gasse, C. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16040442 · Cited by 137
Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism
Ahmed, R. M., Irish, M., Piguet, O., Halliday, G. M., Ittner, L. M., Farooqi, I. S., Hodges, J. R., & Kiernan, M. C. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00380-4 · Cited by 137
Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
Manzo, E., Lorenzini, I., Barrameda, D., O'Conner, A. G., Barrows, J. M., Starr, A., Kovalik, T., Rabichow, B. E., Lehmkuhl, E. M., Shreiner, D. D., et al. (2019) · eLife · doi:10.7554/elife.45114 · Cited by 117
Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics
Zeng, P., Wang, T., Zheng, J., & Zhou, X. (2019) · BMC Medicine · doi:10.1186/s12916-019-1448-9 · Cited by 97
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
Santiago, J. A., Bottero, V., & Potashkin, J. A. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00394 · Cited by 98
A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological Diseases
Rahman, M. H., Peng, S., Hu, X., Chen, C., Rahman, M. R., Uddin, S., Quinn, J. M. W., & Moni, M. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17031035 · Cited by 75
Body mass index and survival from amyotrophic lateral sclerosis
Dardiotis, E., Siokas, V., Sokratous, M., Tsouris, Z., Aloizou, A., Florou, D., Dastamani, M., Mentis, A. A., & Brotis, A. G. (2018) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000521 · Cited by 78
Blood biomarkers and prognosis of amyotrophic lateral sclerosis
Sun, J., Carrero, J. J., Zagai, U., Evans, M., Ingre, C., Yudi Pawitan, Y., & Fang, F. (2020) · European Journal of Neurology · doi:10.1111/ene.14409 · Cited by 70
Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls
Kovanda, A., Leonardis, L., Zidar, J., Koritnik, B., Dolenc‐Grošelj, L., Kovacic, S. R., Curk, T., & Rogelj, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-23139-2 · Cited by 71
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 80
Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
Área-Gómez, E., Larrea, D., Yun, T., Xu, Y., Hupf, J. C., Zandkarimi, F., Chan, R., & Mitsumoto, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-92112-3 · Cited by 68
Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases
Nag, S., & Schneider, J. A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00846-7 · Cited by 69
Diabetes: a tipping point in neurodegenerative diseases
Santiago, J. A., Karthikeyan, M., Lackey, M., Villavicencio, D., & Potashkin, J. A. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.09.005 · Cited by 65
Insulin and Autophagy in Neurodegeneration
de Mello, N. P., Orellana, A. M., Mazucanti, C. H., Lima, G. D. M., Scavone, C., & Kawamoto, E. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00491 · Cited by 57
Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 58
The role of pre‐morbid diabetes on developing amyotrophic lateral sclerosis
D'Ovidio, F., d'Errico, A., Carnà, P., Calvo, A., Costa, G., & Chiò, A. (2018) · European Journal of Neurology · doi:10.1111/ene.13465 · Cited by 59
Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and effect
Gotkine, M., Kviatcovsky, D., & Elinav, E. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1767464 · Cited by 55
Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression
Ioannides, Z. A., Ngo, S. T., Henderson, R. D., McCombe, P., & Steyn, F. J. (2016) · Neurodegenerative Diseases · doi:10.1159/000446502 · Cited by 53
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis
Thompson, A. G., Talbot, K., & Turner, M. R. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327133 · Cited by 54
Metabolic Dysfunction in Spinal Muscular Atrophy
Deguise, M., Chehadé, L., & Kothary, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115913 · Cited by 59
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
Nagel, G., Peter, R. S., Rosenbohm, A., Köenig, W., Dupuis, L., Rothenbacher, D., & Ludolph, A. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-04706-5 · Cited by 54
Environmental risk factors and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in China
Lian, L., Liu, M., Cui, L., Guan, Y., Liu, T., Cui, B., Zhang, K., Tai, H., & Shen, D. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.05.036 · Cited by 47
Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral- Sclerosis Mice
Desseille, C., Deforges, S., Biondi, O., Houdebine, L., D’amico, D., Lamazière, A., Caradeuc, C., Bertho, G., Bruneteau, G., Weill, L., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00332 · Cited by 50
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study
Fasano, A., Fini, N., Ferraro, D., Ferri, L., Vinceti, M., Errals, & Mandrioli, J. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1270325 · Cited by 50
Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases
Li, C. Y., Yang, T. M., Ou, R. W., Wei, Q. Q., & Shang, H. F. (2021) · BMC Medicine · doi:10.1186/s12916-021-01903-y · Cited by 48
The increasing importance of environmental conditions in amyotrophic lateral sclerosis
Riancho, J., Bosque‐Varela, P., Pérez‐Pereda, S., Povedano, M., de Munaín, A. L., & Santurtún, A. (2018) · International Journal of Biometeorology · doi:10.1007/s00484-018-1550-2 · Cited by 49
From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline
Liščić, R. M., Alberici, A., Cairns, N. J., Romano, M., & Buratti, E. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00373-9 · Cited by 48
Life Course Adiposity and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study
Zhang, L., Tang, L., Huang, T., & Fan, D. (2020) · Annals of Neurology · doi:10.1002/ana.25671 · Cited by 41
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
Duan, Q., Wang, H., Su, W., Gu, X., Shen, X., Jiang, Z., Ren, Y., Cao, B., Li, G., Wang, Y., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03314-1 · Cited by 45
Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs
Pfeiffer, R. M., Mayer, B., Kuncl, R. W., Check, D. P., Cahoon, E. K., Rivera, D. R. R., & Freedman, D. M. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2019.1682613 · Cited by 41
Cardiac Findings in Amyotrophic Lateral Sclerosis: A Magnetic Resonance Imaging Study
Rosenbohm, A., Schmid, B., Buckert, D., Rottbauer, W., Kassubek, J., Ludolph, A. C., & Bernhardt, P. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00479 · Cited by 40
Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis
Rosenbohm, A., Nagel, G., Peter, R. S., Brehme, T., Köenig, W., Dupuis, L., Rothenbacher, D., Ludolph, A. C., & for the ALS Registry Study Group (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.5129 · Cited by 38
Antidiabetics, statins and the risk of amyotrophic lateral sclerosis
Mariosa, D., Kamel, F., Bellocco, R., Ronnevi, L. ‐., Almqvist, C., Larsson, H., Ye, W., & Fang, F. (2020) · European Journal of Neurology · doi:10.1111/ene.14190 · Cited by 38
Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy
Nakatsuji, H., Araki, A., Hashizume, A., Hijikata, Y., Yamada, S., Inagaki, T., Suzuki, K., Banno, H., Suga, N., Okada, Y., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8405-3 · Cited by 37
Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival
Wei, Q.-Q., Chen, Y., Cao, B., Ou, R., Zhang, L., Hou, Y., Gao, X., & Shang, H. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0211-y · Cited by 35
The links between diabetes mellitus and amyotrophic lateral sclerosis
Vasta, R., D’Ovidio, F., Logroscino, G., & Chiò, A. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05099-0 · Cited by 38
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study
Moglia, C., Calvo, A., Canosa, A., Bertuzzo, D., Cugnasco, P., Solero, L., Grassano, M., Bersano, E., Cammarosano, S., Manera, U., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1336560 · Cited by 37
Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders
Birajdar, S. V., Mazahir, F., Alam, M. I., Kumar, A., & Yadav, A. K. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176117 · Cited by 37
Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study
Kioumourtzoglou, M., Seals, R. M., Gredal, O., Mittleman, M. A., Hansen, J., & Weisskopf, M. G. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1208247 · Cited by 35
Self-citation
Statins, diabetes mellitus and prognosis of amyotrophic lateral sclerosis: data from 501 patients of a population‐based registry in southwest Germany
Schumacher, J., Peter, R. S., Nagel, G., Rothenbacher, D., Rosenbohm, A., Ludolph, A. C., Dorst, J., & ALS Registry Swabia Study Group (2020) · European Journal of Neurology · doi:10.1111/ene.14300 · Cited by 34
Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women
Eaglehouse, Y. L., Talbott, E. O., Chang, Y., & Kuller, L. H. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4487 · Cited by 34
Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders
Festoff, B. W., & Citron, B. A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00059 · Cited by 31
Topographic distribution of brain iron deposition and small cerebrovascular lesions in amyotrophic lateral sclerosis and in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates
Reuck, J. D., Devos, D., Moreau, C., Auger, F., Durieux, N., Deramecourt, V., Pasquier, F., Maurage, C., Cordonnier, C., Leys, D., et al. (2017) · Acta Neurologica Belgica · doi:10.1007/s13760-017-0832-5 · Cited by 30
Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies
O’Reilly, É. J., Wang, M., Adami, H., Alonso, Á., Bernstein, L., van den Brandt, P. A., Buring, J. E., Daugherty, S. E., Deapen, D., Freedman, D. M., et al. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1452944 · Cited by 29
Risk factors associated with amyotrophic lateral sclerosis based on the observational study: a systematic review and meta-analysis
Zhu, Q., Zhou, J. W., Zhang, Y., Huang, H., Han, J., Cao, B., Xu, D., Zhao, Y., & Chen, G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1196722 · Cited by 29
Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis
Tsai, C., Lee, J. K.-W., & Lee, C. T. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09405-x · Cited by 28
A Knowledge-Based Machine Learning Approach to Gene Prioritisation in Amyotrophic Lateral Sclerosis
Bean, D. M., Al‐Chalabi, A., Dobson, R., & Iacoangeli, A. (2020) · Genes · doi:10.3390/genes11060668 · Cited by 29
Amyotrophic Lateral Sclerosis: A Diet Review
D’Antona, S., Caramenti, M., Porro, D., Castiglioni, I., & Cava, C. (2021) · Foods · doi:10.3390/foods10123128 · Cited by 29
Neutrophils Are Associated with Higher Risk of Incident Amyotrophic Lateral Sclerosis in a BMI ‐ and Age‐Dependent Manner
Cao, W., Cao, Z., Tian, Y., Zhang, L., Wang, W., Tang, L., Xu, C., & Fan, D. (2023) · Annals of Neurology · doi:10.1002/ana.26760 · Cited by 27
Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 U.S. Conflicts
Sagiraju, H. K. R., Živković, S., VanCott, A. C., Patwa, H. S., Gimeno, D., Amuan, M. E., & Pugh, M. J. (2019) · Military Medicine · doi:10.1093/milmed/usz350 · Cited by 25
Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis
Bjørnevik, K., O’Reilly, É. J., Cortese, M., Furtado, J. D., Kolonel, L. N., Marchand, L. L., McCullough, M. L., Paganoni, S., Schwarzschild, M. A., Shadyab, A. H., et al. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1822411 · Cited by 25
Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis
Hu, N., & Ji, H. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06131-7 · Cited by 27
Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction
Pain, O., Jones, A., Khleifat, A. A., Agarwal, D., Hramyka, D., Karoui, H., Kubica, J., Llewellyn, D. J., Ranson, J. M., Yao, Z., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35342 · Cited by 27
Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis
O’Reilly, É. J., Bjørnevik, K., Furtado, J. D., Kolonel, L. N., Marchand, L. L., McCullough, M. L., Stevens, V. L., Shadyab, A. H., Snetselaar, L., Manson, J. E., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008676 · Cited by 26
Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis
Floare, M.-L., & Allen, S. P. (2020) · Neuroscience Insights · doi:10.1177/2633105520957302 · Cited by 25
Finding diseases associated with amyotrophic lateral sclerosis: a total population-based case–control study
Tsai, C., Hu, C., & Lee, C. T. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1522354 · Cited by 24
Glucose clearance and uptake is increased in the SOD1 G93A mouse model of amyotrophic lateral sclerosis through an insulin‐independent mechanism
McDonald, T. S., Kumar, V., Fung, J. N., Woodruff, T. M., & Lee, J. D. (2021) · The FASEB Journal · doi:10.1096/fj.202002450r · Cited by 23
Association between type 2 diabetes and amyotrophic lateral sclerosis
Zhang, L., Tang, L., Huang, T., & Fan, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-06463-6 · Cited by 24
Are diabetes and amyotrophic lateral sclerosis related?
Logroscino, G. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.145 · Cited by 23
Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood
Åberg, M., Nyberg, J., Robertson, J., Kuhn, H. G., Schiöler, L., Nissbrandt, H., Wærn, M., & Torén, K. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8719-1 · Cited by 23
Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches
Zeng, P., Yu, X., & Xu, H. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00543 · Cited by 22
Spinal Cord Metabolic Signatures in Models of Fast- and Slow-Progressing SOD1G93A Amyotrophic Lateral Sclerosis
Valbuena, G. N., Cantoni, L., Tortarolo, M., Bendotti, C., & Keun, H. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01276 · Cited by 23
Joint and interactive effects between health comorbidities and environmental exposures in predicting amyotrophic lateral sclerosis
Bellavia, A., Dickerson, A. S., Rotem, R. S., Hansen, J., Gredal, O., & Weisskopf, M. G. (2020) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2020.113655 · Cited by 22
Self-citation
Hypothalamus and weight loss in amyotrophic lateral sclerosis
Ahmed, R. M., Steyn, F. J., & Dupuis, L. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820107-7.00020-3 · Cited by 20
Life Course of Physical Activity and Risk and Prognosis of Amyotrophic Lateral Sclerosis in a German ALS Registry
Rosenbohm, A., Peter, R., Dorst, J., Kassubek, J., Rothenbacher, D., Nagel, G., Ludolph, A. C., on behalf of the ALS Registry Swabia Study Group, Andres, F., Arnold, G., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012829 · Cited by 20
VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin/IGF signaling
Gao, X. K., Sheng, Z. K., Lu, Y. H., Sun, Y. T., Rao, X. S., Shi, L. J., Cong, X. X., Chen, X., Wu, H. B., Huang, M., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00576-6 · Cited by 20
Shared genetic links between amyotrophic lateral sclerosis and obesity-related traits: a genome-wide association study
Li, C., Ou, R., Gu, X., Wei, Q., & Shang, H. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.023 · Cited by 20
Epidemiology of Amyotrophic Lateral Sclerosis: A Population-Based Study in Israel
Weil, C., Zach, N., Rishoni, S., Shalev, V., & Chodick, G. (2016) · Neuroepidemiology · doi:10.1159/000448921 · Cited by 20
Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored?
Mentis, A. A., Bougea, A. M., & Chrousos, G. P. (2021) · Aging Brain · doi:10.1016/j.nbas.2021.100024 · Cited by 20
Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis via Regulating the Sensitivity of Glucocorticoid Receptor
Gao, C., Chen, X., Xu, A., Cheng, K. K. Y., & Shen, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0785-y · Cited by 19
Diabetes mellitus is associated with a lower risk of amyotrophic lateral sclerosis: A systematic review and meta-analysis
Wannarong, T., & Ungprasert, P. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106248 · Cited by 17
Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge
Riancho, J., Delgado‐Alvarado, M., Andreu, M. D., Paz‐Fajardo, L., Arozamena, S., Gil-Bea, F. J., & de Munaín, A. L. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15151 · Cited by 18
Shared Pathological Mechanisms Between Diabetes Mellitus and Neurodegenerative Diseases
Nasrolahi, A., Mahmoudi, J., Noori-Zadeh, A., Haghani, K., Bakhtiyari, S., & Darabi, S. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00191-8 · Cited by 20
Type 2 Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Genetic Overlap, Causality, and Mediation
Chen, H., Zhang, J., Wang, T., Zhang, S., Lai, Q., Huang, S., & Zeng, P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab465 · Cited by 17
Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms
Han, Y., & He, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1189809 · Cited by 18
Key Disease Mechanisms Linked to Amyotrophic Lateral Sclerosis in Spinal Cord Motor Neurons
Bottero, V., Santiago, J. A., Quinn, J. P., & Potashkin, J. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.825031 · Cited by 17
Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review
Ferri, L., Ajdinaj, P., Rispoli, M. G., Carrarini, C., Barbone, F., D’Ardes, D., Capasso, M., Muzio, A. D., Cipollone, F., ONOFRJ, M. C., et al. (2021) · Biomolecules · doi:10.3390/biom11060867 · Cited by 17
The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: a center-based survey in China
Zhang, L., Chen, L., & Fan, D. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2019.1704010 · Cited by 16
Cardiovascular Diseases, Medications, and ALS: A Population-Based Case-Control Study
Abdel Magid, H. S., Topol, B., McGuire, V., Hinman, J. A., Kasarskis, E. J., & Nelson, L. M. (2022) · Neuroepidemiology · doi:10.1159/000526982 · Cited by 15
Exploring Relevant Time Windows in the Association Between PM2.5 Exposure and Amyotrophic Lateral Sclerosis: A Case-Control Study in Denmark
Nunez, Y., Balalian, A. A., Parks, R. M., He, M. Z., Hansen, J., Raaschou‐Nielsen, O., Ketzel, M., Khan, J., Brandt, J., Vermeulen, R. C. H., et al. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad099 · Cited by 15
Self-citation
Trends in the clinical features of amyotrophic lateral sclerosis: A 14‐year Chinese cohort study
Chen, L., Xu, L., Tang, L., Xia, K., Tian, D., Zhang, G., Wang, Y., Yu, Z., Ma, J., Zhang, Y., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14943 · Cited by 15
Statin Initiation and Risk of Amyotrophic Lateral Sclerosis
Skajaa, N., Bakos, I., Horváth–Puhó, E., Henderson, V. W., Lash, T. L., & Sørensen, H. T. (2021) · Epidemiology · doi:10.1097/ede.0000000000001384 · Cited by 15
Prognostic Nomogram Associated with Longer Survival in Amyotrophic Lateral Sclerosis Patients
Wei, Q., Chen, Y., Chen, X., Cao, B., Ou, R., Zhang, L., Hou, Y., & Shang, H. (2018) · Aging and Disease · doi:10.14336/ad.2017.1016 · Cited by 15
Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases
Brütting, C., Emmer, A., Kornhuber, M. E., & Staege, M. S. (2017) · BioMed Research International · doi:10.1155/2017/7973165 · Cited by 14
Exploring the Role of Metabolic Hormones in Amyotrophic Lateral Sclerosis
Moțățăianu, A., Mănescu, I. B., Şerban, G. M., Bărcuţean, L., Ion, V., Bălașa, R., & Andone, S. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105059 · Cited by 13
Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder
Nash, Y., & Sitty, M. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-210632 · Cited by 13
Type 2 diabetes, obesity, and risk of amyotrophic lateral sclerosis: A population‐based cohort study
Skajaa, N., Riahi, E. B., Szépligeti, S. K., Horváth–Puhó, E., Sørensen, H. T., Henderson, V. W., & Sørensen, H. T. (2023) · Brain and Behavior · doi:10.1002/brb3.3007 · Cited by 12
Proteomic investigation of ALS motor cortex identifies known and novel pathogenetic mechanisms
Lee, A., Henderson, R. D., Arachchige, B. J., Robertson, T., & McCombe, P. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120753 · Cited by 12
The potential interplay between energy metabolism and innate complement activation in amyotrophic lateral sclerosis
McDonald, T. S., McCombe, P., Woodruff, T. M., & Lee, J. D. (2020) · The FASEB Journal · doi:10.1096/fj.201901781 · Cited by 12
Premorbid lipid levels and long-term risk of ALS—a population-based cohort study
Vaage, A. M., Benth, J. Š., Meyer, H. E., Holmøy, T., & Nakken, O. (2023) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2023.2295455 · Cited by 13
Prediagnostic plasma branched-chain amino acids and the risk of amyotrophic lateral sclerosis
Bjørnevik, K., O’Reilly, É. J., Berry, J. D., Clish, C. B., Jeanfavre, S., Kato, I., Kolonel, L. N., Marchand, L. L., McCullough, M. L., Paganoni, S., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006669 · Cited by 10

Authors: Kioumourtzoglou, M.-A., Rotem, R. S., Seals, R. M., Gredal, O., Hansen, J., & Weisskopf, M. G.
Affiliations: Harvard University (US)
National Rehabilitation Center for Neuromuscular Disorders, Copenhagen, Denmark
Danish Cancer Society (DK)
Corresponding author: Kioumourtzoglou, Marianthi-Anna
ORCID: Kioumourtzoglou, Marianthi-Anna
Rotem, Ran S.
Seals, Ryan M.
Hansen, Johnni
Weisskopf, Marc G.
Venue: JAMA Neurology
Publisher: American Medical Association (AMA)
Published: 2015-08-01
Volume: 72
Issue: 8
Pages: 905
ISSN: 2168-6149 (ISSN-L)
DOI: 10.1001/jamaneurol.2015.0910
PMC: PMC4975611
OpenAlex: W1585186077
Cited by: 145
References: 60
Citations by year: 2026: 3 · 2025: 7 · 2024: 14 · 2023: 15 · 2022: 8 · 2021: 21 · 2020: 21 · 2019: 15 · 2018: 12 · 2017: 17 · 2016: 10 · 2015: 1
FWCI: 9.40
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA Neurology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Environmental Health Sciences (P30ES000002, R01ES019188, T32ES007069)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords: amyotrophic lateral sclerosis, diabetes mellitus, obesity, type 2 diabetes, type 1 diabetes, cardiometabolic risk factors, vascular risk factors, motor neuron disease, age at diagnosis, sex differences
MeSH terms: Adult, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Denmark, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Obesity, Registries, Risk Factors, Incidence, Case-Control Studies, Protective Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks